Literature DB >> 7761103

Fibroblast growth factor receptor-1 regulation of Src family kinases.

E Landgren1, P Blume-Jensen, S A Courtneidge, L Claesson-Welsh.   

Abstract

Fibroblast growth factors (FGFs) induce proliferation and differentiation of a wide variety of cells by stimulation of cell surface expressed high affinity-binding receptor tyrosine kinases. Members of the Src family of cytoplasmic tyrosine kinases are substrates for certain growth factor receptors. We have examined interactions between FGF receptor-1 (FGFR-1) and Src, Fyn and Yes. In lung capillary endothelial cells and murine fibroblasts, bFGF stimulation led to increased autophosphorylation of Src family members. In contrast, in porcine aortic endothelial cells (FGFR-1/PAE) and lung fibroblasts from chinese hamster (CCL 39), activation of FGFR caused reduced autophosphorylation of Src and Fyn. In neither case could complex-formation between Src members and FGFR be seen. Analysis of a panel of mutated FGFR-1 expressed in PAE cells showed that FGFR-1/Y766F mediated an increased autophosphorylation of Src members and upregulation of their kinase activities. Y766 in FGFR-1 has been shown to serve as a binding site for phospholipase C-gamma, which regulates Ca2+ fluxes and protein kinase C (PKC) activity. The negative effect on Src kinase activity upon FGFR stimulation was mimicked by activation of PKC in FGFR-1/PAE or CCL 39 cells using phorbol 12-myristate 13-acetate (PMA) and Src was phosphorylated in vitro by purified recombinant PKC alpha. Moreover, inhibition of PKC attenuated the bFGF induced decrease in autophosphorylation of Src family members. These data indicate a negative regulatory role for PKC on Src kinase activity in certain cell types.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7761103

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Src activation decouples cell division orientation from cell geometry in mammalian cells.

Authors:  Xiaoyan Sun; Hongsheng Qi; Xiuzhen Zhang; Li Li; Jiaping Zhang; Qunli Zeng; George S Laszlo; Bo Wei; Tianhong Li; Jianxin Jiang; Alex Mogilner; Xiaobing Fu; Min Zhao
Journal:  Biomaterials       Date:  2018-04-03       Impact factor: 12.479

2.  Molecular mechanism and functional implications of thrombin-mediated tyrosine phosphorylation of PKCdelta in platelets.

Authors:  Swaminathan Murugappan; Haripriya Shankar; Surya Bhamidipati; Robert T Dorsam; Jianguo Jin; Satya P Kunapuli
Journal:  Blood       Date:  2005-04-05       Impact factor: 22.113

3.  Differential regulation of potassium currents by FGF-1 and FGF-2 in embryonic Xenopus laevis myocytes.

Authors:  R Chauhan-Patel; A E Spruce
Journal:  J Physiol       Date:  1998-10-01       Impact factor: 5.182

4.  Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction.

Authors:  M Mohammadi; I Dikic; A Sorokin; W H Burgess; M Jaye; J Schlessinger
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

5.  Differentiation of central nervous system neuronal cells by fibroblast-derived growth factor requires at least two signaling pathways: roles for Ras and Src.

Authors:  W L Kuo; K C Chung; M R Rosner
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

6.  Is expression or activation of Src kinase associated with cancer-specific survival in ER-, PR- and HER2-negative breast cancer patients?

Authors:  Beatrix Elsberger; Bingchao A Tan; Thomas J Mitchell; Sylvia B F Brown; Elizabeth A Mallon; Sian M Tovey; Timothy G Cooke; Valerie G Brunton; Joanne Edwards
Journal:  Am J Pathol       Date:  2009-09-17       Impact factor: 4.307

7.  Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos.

Authors:  J Partanen; L Schwartz; J Rossant
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

8.  AKT1 mediates bypass of the G1/S checkpoint after genotoxic stress in normal human cells.

Authors:  Madhu A Lal; Dongsoon Bae; Tura C Camilli; Steven R Patierno; Susan Ceryak
Journal:  Cell Cycle       Date:  2009-05-25       Impact factor: 4.534

Review 9.  Improving the prognosis for patients with glioblastoma: the rationale for targeting Src.

Authors:  John de Groot; Vanessa Milano
Journal:  J Neurooncol       Date:  2009-05-13       Impact factor: 4.130

10.  Activity of the multikinase inhibitor dasatinib against ovarian cancer cells.

Authors:  G E Konecny; R Glas; J Dering; K Manivong; J Qi; R S Finn; G R Yang; K-L Hong; C Ginther; B Winterhoff; G Gao; J Brugge; D J Slamon
Journal:  Br J Cancer       Date:  2009-10-27       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.